Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

KANAMYCIN A for Pulmonary tuberculosis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 17 adverse event reports in the FDA FAERS database where KANAMYCIN A was used for Pulmonary tuberculosis.

Most Reported Side Effects for KANAMYCIN A

Side Effect Reports % Deaths Hosp.
Drug resistance 21 23.9% 5 4
Treatment failure 18 20.5% 10 2
Electrocardiogram qt prolonged 10 11.4% 2 0
Anaemia 6 6.8% 0 1
Drug reaction with eosinophilia and systemic symptoms 6 6.8% 0 0
Hepatotoxicity 6 6.8% 0 4
Multiple-drug resistance 6 6.8% 4 1
Nausea 6 6.8% 1 1
Off label use 6 6.8% 2 2
Pathogen resistance 6 6.8% 1 2
Deafness 5 5.7% 1 0
Depression 5 5.7% 1 0
Drug ineffective 5 5.7% 0 0
Neuropathy peripheral 5 5.7% 1 0
Treatment noncompliance 5 5.7% 2 2

Other Indications for KANAMYCIN A

Tuberculosis (51) Bacterial infection (6) Product used for unknown indication (5)

Other Drugs Used for Pulmonary tuberculosis

ISONIAZID (1,249) RIFAMPIN (1,192) PYRAZINAMIDE (1,134) ETHAMBUTOL (1,073) LINEZOLID (905) BEDAQUILINE (615) CLOFAZIMINE (473) MOXIFLOXACIN (413) DELAMANID (408) LEVOFLOXACIN (394)

Related Pages

KANAMYCIN A Full Profile All Pulmonary tuberculosis Drugs KANAMYCIN A Demographics KANAMYCIN A Timeline